BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16679299)

  • 1. Lercanidipine and losartan effects on blood pressure and fibrinolytic parameters.
    Lin TH; Voon WC; Yen HW; Huang CH; Su HM; Lai WT; Sheu SH
    Kaohsiung J Med Sci; 2006 Apr; 22(4):177-83. PubMed ID: 16679299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension.
    James IG; Jones A; Davies P
    J Hum Hypertens; 2002 Aug; 16(8):605-10. PubMed ID: 12149668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
    Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lercanidipine vs lacidipine in isolated systolic hypertension.
    Millar-Craig M; Shaffu B; Greenough A; Mitchell L; McDonald C
    J Hum Hypertens; 2003 Nov; 17(11):799-806. PubMed ID: 14578921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure effects of the angiotensin II receptor blocker, losartan.
    Weber MA; Byyny RL; Pratt JH; Faison EP; Snavely DB; Goldberg AI; Nelson EB
    Arch Intern Med; 1995 Feb; 155(4):405-11. PubMed ID: 7848024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losartan and lercanidipine attenuate low-density lipoprotein oxidation in patients with hypertension and type 2 diabetes mellitus: a randomized, prospective crossover study.
    Rachmani R; Levi Z; Zadok BS; Ravid M
    Clin Pharmacol Ther; 2002 Sep; 72(3):302-7. PubMed ID: 12235451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of angiotensin II receptor blockade and the DASH diet on markers of endogenous fibrinolysis.
    Erlinger TP; Conlin PR; Macko RF; Bohannon AD; Miller ER; Moore TJ; Svetkey LP; Appel LJ
    J Hum Hypertens; 2002 Jun; 16(6):391-7. PubMed ID: 12037693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of aliskiren and losartan on fibrinolysis and insulin sensitivity in hypertensive patients with metabolic syndrome.
    Fogari R; Zoppi A; Mugellini A; Lazzari P; Derosa G
    Horm Metab Res; 2010 Nov; 42(12):892-6. PubMed ID: 20814848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lercanidipine in the treatment of hypertension.
    Beckey C; Lundy A; Lutfi N
    Ann Pharmacother; 2007 Mar; 41(3):465-73. PubMed ID: 17341540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparative study of the effects of treatment with once-daily, niacin extended-release/lovastatin and with simvastatin on lipid profile and fibrinolytic parameters in Taiwan.
    Lin TH; Voon WC; Yen HW; Huang CH; Su HM; Lai WT; Sheu SH
    Kaohsiung J Med Sci; 2006 Jun; 22(6):257-65. PubMed ID: 16793562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertension.
    Saruta T; Ogihara T; Matsuoka H; Suzuki H; Toki M; Hirayama Y; Nonaka K; Takahashi K
    Hypertens Res; 2007 Aug; 30(8):729-39. PubMed ID: 17917321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients.
    Fogari R; Mugellini A; Zoppi A; Corradi L; Preti P; Lazzari P; Derosa G
    Am J Hypertens; 2002 Apr; 15(4 Pt 1):316-20. PubMed ID: 11991216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.
    Pareek A; Basavanagowdappa H; Zawar S; Kumar A; Chandurkar N
    Expert Opin Pharmacother; 2009 Jul; 10(10):1529-36. PubMed ID: 19514864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does antihypertensive therapy affect the natural protection against thrombosis?
    Gleerup G; Hedner T; Hjørting Hansen E; Winther K
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S34-6. PubMed ID: 1720483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of psychosomatic symptomatology in hypertensive patients treated with lercanidipine (LERCAPSICO study)].
    Abellán Alemán J; Martínez García JF; Merino Sánchez J; Gil Guillén V; Latorre Hernández J; Fernández Montero F; Navarro Lima A;
    An Med Interna; 2003 Jun; 20(6):287-91. PubMed ID: 12848598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance.
    Fogari R; Derosa G; Lazzari P; Zoppi A; Fogari E; Rinaldi A; Mugellini A
    Am J Hypertens; 2004 Sep; 17(9):823-7. PubMed ID: 15363826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cilnidipine on lipids, lipoproteins and fibrinolytic system in hypertensive patients.
    Ahaneku JE; Sakata K; Uranol T; Takada Y; Takada A
    Drugs Exp Clin Res; 2000; 26(4):119-23. PubMed ID: 11109511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: placebo-controlled, randomized, crossover study with four ABPM.
    Puig JG; Calvo C; Luurila O; Luurila H; Sulosaari S; Strandberg A; Ghezzi C
    J Hum Hypertens; 2007 Dec; 21(12):917-24. PubMed ID: 17581601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.